WeVote

Bill

Bill

SB 233

An Act relating to the Controlled Substances Advisory Committee.

34th Legislature (2025-2026) Introduced by Matt Claman

SB 233 modifies Alaska's Controlled Substances Advisory Committee structure, recently advanced from Senate Labor & Commerce Committee with public testimony considered.

(S) Heard & Held -- Please Note Time Change --
0
WeVote Research Nonpartisan
Bill Summary · SB 233

Legislative bill overview

SB 233 modifies the structure, composition, or authority of Alaska's Controlled Substances Advisory Committee. The bill recently passed out of the Senate Labor & Commerce Committee and is awaiting transmittal for further consideration. The specific provisions are not detailed in the available action summary.

Why is this important

The Controlled Substances Advisory Committee shapes Alaska's policy responses to drug regulation, addiction treatment, and substance abuse prevention. Changes to this committee's composition or mandate can influence how the state approaches controlled substance management and public health strategies related to drug policy.

Potential points of contention

  • Committee representation balance: Disagreement over who should hold seats on the committee (law enforcement vs. public health advocates vs. industry stakeholders) and whether the current composition reflects all affected interests
  • Scope of advisory authority: Uncertainty about whether expanded or narrowed committee powers could either meaningfully influence policy or exceed appropriate advisory boundaries
  • Transparency and accountability: Questions about committee meeting procedures, record-keeping, and whether advisory recommendations are publicly accessible and acted upon

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.